Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-25 @ 11:53 PM
Study NCT ID:
NCT05304494
Status:
WITHDRAWN
Last Update Posted:
2022-05-13
First Post:
2022-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
Sponsor:
Sanome
Organization:
Study Overview
Official Title:
Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
Status:
WITHDRAWN
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Limited resources
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Sentinel-001 study aims to identify a combination of biomarkers suitable for triage of breathlessness.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: